Combination Treatment for Moderate to Severe Acne
Information source: Medicis Global Service Corporation
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Acne
Intervention: Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Medicis Global Service Corporation Official(s) and/or principal investigator(s): Mary Sanstead, BSN, CCRP, Study Chair, Affiliation: Medicis Global Service Corporation
Summary
To determine if a combination of three currently approved acne products are safe and
effective for the treatment of moderate to severe acne
Clinical Details
Official title: A Phase IV, Open-Label Study Evaluating the Use of Solodyn (Minocycline HCL Extended-Release Tablets), Ziana, and Triaz Foaming Cloths as Combination Acne Therapy Prior to Treatment With Isotretinoin
Study design: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Primary outcome: Proportion of patients showing improvement from Baseline and Week 12
Detailed description:
A Phase IV, Open-Label Study Evaluating the treatment for Combination Acne Therapy.
Eligibility
Minimum age: 12 Years.
Maximum age: 30 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- moderate to severe acne, IGA = 3 or 4 (Investigator Global Assessment)
Exclusion Criteria:
- pregnancy and allergies
Locations and Contacts
Birmingham, Alabama, United States
Santa Monica, California, United States
Hockessin, Delaware, United States
Chestnut Hill, Massachusetts, United States
Detroit, Michigan, United States
Henderson, Nevada, United States
High Point, North Carolina, United States
Hershey, Pennsylvania, United States
Nashville, Tennessee, United States
Salt Lake City, Utah, United States
Additional Information
Starting date: September 2010
Last updated: November 28, 2011
|